Back to GetFilings.com



Table of Contents
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
x
 
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 For the quarterly period ended June 30, 2002 or
 
¨
 
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 For the period from              to             
 
Commission file number 0-5404
 

 
 
ANALEX CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
71-0869563
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
 
5904 Richmond Highway
Suite 300
Alexandria, Virginia 22303
(Address of principal executive offices)
 
Registrant’s Telephone number including area code
(703) 329-9400
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:
 
Yes    x
 
No    ¨             
 
As of August 6, 2002, 14,385,855 shares of the Common Stock of the registrant were outstanding.


Table of Contents
ANALEX CORPORATION
TABLE OF CONTENTS
 
           
Page No.

Part I    Financial Information:
      
Item 1.
  
Financial Statements
      
         
3
         
5
         
6
         
7
Item 2.
       
15
Item 3.
       
19
      
Item 1.
       
20
Item 4.
       
20
Item 6.
       
21
    
23
 


Table of Contents
ANALEX CORPORATION
CONSOLIDATED BALANCE SHEETS
JUNE 30, 2002 AND DECEMBER 31, 2001
 
    
June 30, 2002

  
December 31, 2001

ASSETS
             
Current assets:
             
Cash and cash equivalents
  
$
369,200
  
$
83,100
Accounts receivable, net
  
 
11,106,000
  
 
9,152,800
Prepaid expenses and other
  
 
496,600
  
 
223,300
    

  

Total current assets
  
 
11,971,800
  
 
9,459,200
    

  

Fixed assets, net
  
 
328,700
  
 
260,600
Goodwill and other intangibles, net
  
 
16,363,100
  
 
16,488,600
Contract Rights
  
 
991,100
  
 
—  
Deferred finance costs
  
 
241,500
  
 
72,500
Other
  
 
91,900
  
 
119,400
    

  

Total other assets
  
 
18,016,300
  
 
16,941,100
    

  

Total assets
  
$
29,988,100
  
$
26,400,300
    

  

 
 
 
 
See Notes to Consolidated Financial Statements

3


Table of Contents
ANALEX CORPORATION
CONSOLIDATED BALANCE SHEETS
JUNE 30, 2002 AND DECEMBER 31, 2001
 
    
June 30,
2002

    
December 31, 2001

 
LIABILITIES AND SHAREHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
1,401,400
 
  
$
1,371,400
 
Note payable - line of credit
  
 
3,474,000
 
  
 
1,696,500
 
Note payable - bank term note
  
 
700,000
 
  
 
700,000
 
Notes payable - other
  
 
968,300
 
  
 
838,500
 
Other current liabilities
  
 
5,509,700
 
  
 
4,779,400
 
    


  


Total current liabilities
  
 
12,053,400
 
  
 
9,385,800
 
    


  


Note payable - bank term note
  
 
2,392,000
 
  
 
2,741,600
 
Notes payable - other
  
 
2,600,100
 
  
 
2,262,600
 
Other
  
 
779,000
 
  
 
835,200
 
    


  


Total long-term liabilities
  
 
5,771,100
 
  
 
5,839,400
 
    


  


Commitments and contingencies
                 
Total liabilities
  
 
17,824,500
 
  
 
15,225,200
 
    


  


Shareholders’ equity:
                 
Common stock $.02 par; authorized 20,000,000 shares;
issued and outstanding - June 30, 2002 14,385,855 shares
and December 31, 2001, 14,375,975 shares
  
 
288,900
 
  
 
287,500
 
Additional capital
  
 
21,160,800
 
  
 
20,726,300
 
Deferred compensation
  
 
(17,200
)
  
 
(22,300
)
Accumulated other comprehensive loss
  
 
(52,200
)
  
 
—  
 
Accumulated deficit
  
 
(9,216,700
)
  
 
(9,816,400
)
    


  


Total shareholders’ equity
  
 
12,163,600
 
  
 
11,175,100
 
    


  


Total liabilities and shareholders’ equity
  
$
29,988,100
 
  
$
26,400,300
 
    


  


 
 
 
See Notes to Consolidated Financial Statements

4


Table of Contents
ANALEX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2002 AND 2001
 
    
Three Months Ended
June 30,

    
Six Months Ended
June 30,

 
    
2002

    
2001

    
2002

    
2001

 
Revenues
  
$
12,928,200
 
  
$
4,357,600
 
  
$
25,963,700
 
  
$
8,587,500
 
Operating costs and expenses:
                                   
Costs of revenue
  
 
11,231,100
 
  
 
3,503,600
 
  
 
22,260,000
 
  
 
7,009,200
 
Selling, general and administrative
  
 
1,144,700
 
  
 
663,500
 
  
 
2,397,300
 
  
 
1,220,100
 
Amortization of goodwill and other intangibles
  
 
74,500
 
  
 
84,000
 
  
 
140,000
 
  
 
168,000
 
    


  


  


  


Total operating costs and expenses
  
 
12,450,300
 
  
 
4,251,100
 
  
 
24,797,300
 
  
 
8,397,300
 
    


  


  


  


Operating income
  
 
477,900
 
  
 
106,500
 
  
 
1,166,400
 
  
 
190,200
 
    


  


  


  


Other income (expense):
                                   
Interest income
  
 
500
 
  
 
—  
 
  
 
600
 
  
 
—  
 
Interest expense
  
 
(241,900
)
  
 
(34,000
)
  
 
(510,400
)
  
 
(72,000
)
Other expense
  
 
(27,900
)
  
 
(100
)
  
 
(43,300
)
  
 
(24,500
)
    


  


  


  


Total other expense
  
 
(269,300
)
  
 
(34,100
)
  
 
(553,100
)
  
 
(96,500
)
    


  


  


  


Income before income taxes
  
 
208,600
 
  
 
72,400
 
  
 
613,300
 
  
 
93,700
 
Provision for income taxes
  
 
4,200
 
  
 
—  
 
  
 
13,700
 
  
 
—  
 
    


  


  


  


Net income
  
$
204,400
 
  
$
72,400
 
  
$
599,600
 
  
$
93,700
 
    


  


  


  


Net income per share:
 
                                   
Basic
  
$
0.01
 
  
$
0.01
 
  
$
0.04
 
  
$
0.01
 
    


  


  


  


Diluted
  
$
0.01
 
  
$
0.01
 
  
$
0.04
 
  
$
0.01
 
    


  


  


  


Weighted average number of shares:
 
                                   
Basic
  
 
14,395,177
 
  
 
6,517,780
 
  
 
14,390,477
 
  
 
6,511,787
 
    


  


  


  


Diluted
  
 
16,997,139
 
  
 
7,985,845
 
  
 
16,887,701
 
  
 
7,882,512
 
    


  


  


  


 
 
 
See Notes to Consolidated Financial Statements

5


Table of Contents
ANALEX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2002 AND 2001
 
    
JUNE 30,

 
    
2002

    
2001

 
Cash flows from operating activities:
                 
Net income
  
$
599,600
 
  
$
93,700
 
    


  


Adjustments to reconcile net income to net cash
provided (used) by operating activities:
                 
Depreciation
  
 
55,800
 
  
 
68,900
 
Amortization of goodwill and other intangibles
  
 
140,000
 
  
 
168,000
 
Amortization of finance costs
  
 
176,500
 
  
 
—  
 
Stock compensation expense
  
 
5,100
 
  
 
2,700
 
Changes in operating assets and liabilities:
                 
Accounts receivable
  
 
(1,953,200
)
  
 
(201,400
)
Prepaid expenses and other
  
 
(273,300
)
  
 
(139,100
)
Other assets
  
 
27,500
 
  
 
(5,300
)
Accounts payable
  
 
24,700
 
  
 
(230,400
)
Other current liabilities
  
 
677,900
 
  
 
260,600
 
Other long-term liabilities
  
 
(56,200
)
  
 
—  
 
    


  


Total adjustments
  
 
(1,175,200